Search research articles
Contact Us
Filters
Showing results (461-470 of 510) with videos related to
Page
of 51
Sort By:
Neurology(R) Neuroimmunology & Neuroinflammation
|
September 18, 2025
Persons With Multiple Sclerosis Reveal Distinct Kynurenine Pathway Metabolite Patterns: A Multinational Cross-Sectional Study
Marie Kupjetz, Martin Langeskov-Christensen, Morten Riemenschneider, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
February 12, 2026
Persons With Multiple Sclerosis Reveal Distinct Kynurenine Pathway Metabolite Patterns: A Multinational Cross-Sectional Study
Marie Kupjetz, Martin Langeskov-Christensen, Morten Riemenschneider, et al.
The Lancet. Gastroenterology & Hepatology
|
June 27, 2017
Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trial
Tim Meyer, Richard Fox, Yuk Ting Ma, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 28, 2020
Phase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinoma
Richard S Finn, Masafumi Ikeda, Andrew X Zhu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 6, 2019
Safety and Efficacy of Nivolumab Monotherapy in Recurrent or Metastatic Cervical, Vaginal, or Vulvar Carcinoma: Results From the Phase I/II CheckMate 358 Trial
R Wendel Naumann, Antoine Hollebecque, Tim Meyer, et al.
Nature Communications
|
August 18, 2018
The VAR2CSA malaria protein efficiently retrieves circulating tumor cells in an EpCAM-independent manner
Mette Ø Agerbæk, Sara R Bang-Christensen, Ming-Hsin Yang, et al.
The Lancet. Oncology
|
October 28, 2017
Efficacy and safety of long-acting pasireotide or everolimus alone or in combination in patients with advanced carcinoids of the lung and thymus (LUNA): an open-label, multicentre, randomised, phase 2 trial
Piero Ferolla, Maria Pia Brizzi, Tim Meyer, et al.
ESMO Open
|
August 28, 2020
Second-line cabozantinib after sorafenib treatment for advanced hepatocellular carcinoma: a subgroup analysis of the phase 3 CELESTIAL trial
Robin Kate Kelley, Baek-Yeol Ryoo, Philippe Merle, et al.
British Journal of Sports Medicine
|
May 27, 2022
International Olympic Committee (IOC) consensus statement on acute respiratory illness in athletes part 2: non-infective acute respiratory illness
Martin Schwellnus, Paolo Emilio Adami, Valerie Bougault, et al.
Nature Communications
|
June 7, 2022
Author Correction: The VAR2CSA malaria protein efficiently retrieves circulating tumor cells in an EpCAM-independent manner
Mette Ø Agerbæk, Sara R Bang-Christensen, Ming-Hsin Yang, et al.
Page
of 51
Search research articles
Search
Showing results (461-470 of 510) with videos related to
Sort By:
Page
of 51
Neurology(R) Neuroimmunology & Neuroinflammation
|
September 18, 2025
Persons With Multiple Sclerosis Reveal Distinct Kynurenine Pathway Metabolite Patterns: A Multinational Cross-Sectional Study
Marie Kupjetz, Martin Langeskov-Christensen, Morten Riemenschneider, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
February 12, 2026
Persons With Multiple Sclerosis Reveal Distinct Kynurenine Pathway Metabolite Patterns: A Multinational Cross-Sectional Study
Marie Kupjetz, Martin Langeskov-Christensen, Morten Riemenschneider, et al.
The Lancet. Gastroenterology & Hepatology
|
June 27, 2017
Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trial
Tim Meyer, Richard Fox, Yuk Ting Ma, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 28, 2020
Phase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinoma
Richard S Finn, Masafumi Ikeda, Andrew X Zhu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 6, 2019
Safety and Efficacy of Nivolumab Monotherapy in Recurrent or Metastatic Cervical, Vaginal, or Vulvar Carcinoma: Results From the Phase I/II CheckMate 358 Trial
R Wendel Naumann, Antoine Hollebecque, Tim Meyer, et al.
Nature Communications
|
August 18, 2018
The VAR2CSA malaria protein efficiently retrieves circulating tumor cells in an EpCAM-independent manner
Mette Ø Agerbæk, Sara R Bang-Christensen, Ming-Hsin Yang, et al.
The Lancet. Oncology
|
October 28, 2017
Efficacy and safety of long-acting pasireotide or everolimus alone or in combination in patients with advanced carcinoids of the lung and thymus (LUNA): an open-label, multicentre, randomised, phase 2 trial
Piero Ferolla, Maria Pia Brizzi, Tim Meyer, et al.
ESMO Open
|
August 28, 2020
Second-line cabozantinib after sorafenib treatment for advanced hepatocellular carcinoma: a subgroup analysis of the phase 3 CELESTIAL trial
Robin Kate Kelley, Baek-Yeol Ryoo, Philippe Merle, et al.
British Journal of Sports Medicine
|
May 27, 2022
International Olympic Committee (IOC) consensus statement on acute respiratory illness in athletes part 2: non-infective acute respiratory illness
Martin Schwellnus, Paolo Emilio Adami, Valerie Bougault, et al.
Nature Communications
|
June 7, 2022
Author Correction: The VAR2CSA malaria protein efficiently retrieves circulating tumor cells in an EpCAM-independent manner
Mette Ø Agerbæk, Sara R Bang-Christensen, Ming-Hsin Yang, et al.
Page
of 51